Skip to main content

Series B Oncology Companies

Explore 26 oncology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
26
Total Funding
$1.6B
Avg Funding
$65.5M
Cities
18

Export 26 Series B Oncology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
London, United Kingdom
$16.3M
raised

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

Sep 2024
Series B

Founder Contacts

30,000+ verified contacts

Boston, United States
$175.0M
raised

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

Sep 2024
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$50.0M
raised

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

Aug 2021
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$58.0M
raised

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

Aug 2021
Series B

Founder Contacts

30,000+ verified contacts

Oakland, United States
$46.0M
raised

xCures is a SaaS platform that aggregates, organizes and structures EMRs providing multimodal data across all diseases.

Jun 2026
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 26 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Woburn, United States
$7.3M
raised

Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.

Jun 2026
Series B

Founder Contacts

30,000+ verified contacts

Philadelphia, United States

We are the first HIPAA compliant platform that focuses on optimizing cancer treatment plans for patients in China locally, on a B2B model.

May 2023
Series B

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Triomics is a generative AI-powered platform that matches patients to clinical trials.

May 2026
Series B

Founder Contacts

30,000+ verified contacts

Chiba, Japan
$2.0M
raised

Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.

May 2025
Series B

Founder Contacts

30,000+ verified contacts

Waltham, United States
$150.0M
raised

BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.

Apr 2022
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 26 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Duarte, United States
$33.0M
raised

AccessHope provides cancer care, support and expertise for employees.

Apr 2024
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$77.0M
raised

Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.

Mar 2026
Series B

Founder Contacts

30,000+ verified contacts

London, United Kingdom
$30.0M
raised

Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.

Feb 2023
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$47.0M
raised

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

Oct 2025
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$60.0M
raised

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

Sep 2025
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 26 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
New Haven, United States
$75.0M
raised

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

Jan 2025
Series B

Founder Contacts

30,000+ verified contacts

Atlanta, United States
$16.0M
raised

OncoLens replaces the current labor intensive process of patient case collaboration and subsequent CoC accreditation in cancer care.

Oct 2024
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$120.0M
raised

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

Aug 2024
Series B

Founder Contacts

30,000+ verified contacts

Seattle, United States
$112.0M
raised

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Feb 2024
Series B

Founder Contacts

30,000+ verified contacts

Watertown, United States
$175.0M
raised

Mariana Oncology is a biotechnology research industry.

Sep 2023
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 26 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Vancouver, Canada
$142.0M
raised

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Apr 2023
Series B

Founder Contacts

30,000+ verified contacts

Palo Alto, United States
$25.0M
raised

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

Jan 2023
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$84.0M
raised

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Dec 2025
Series B

Founder Contacts

30,000+ verified contacts

New York, United States
$91.0M
raised

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Boston, United States
$45.0M
raised

Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Showing 1 to 25 of 26 companies

Ready to Connect with Series B Oncology Startups?

Get verified founder emails, funding details, and company data for 26 series b oncology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked